Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized double-blind placebo-controlled trial of ramelteon tablets for sleep-onset insomnia
CTR20242517Phase 3Completed
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ramelteon in chronic insomnia, Insomnia, sponsored by Chia Tai-Tianqing Pharmaceutical Group. Started Jul 2024; status: completed.
02
Drugs
ramelteon
03
Conditions
chronic insomniaInsomnia
Beyond the preview
Go deeper on CTR20242517.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20242517.